#United States #Digital Pathology #Madison Heights #Mopec #Lumea

Mopec Strengthens Collaboration with Lumea for Digital Pathology

In a significant move for the future of digital pathology, Mopec has announced the expansion of its collaboration with Lumea on September 28, 2025. This partnership aims to significantly enhance diagnostic accuracy and workflow efficiency in pathology labs globally. With a focus on integrating Lumea's patented tissue-handling technology into the Mopec Maestro® Encore Grossing Station, the collaboration marks an important milestone in their mission to provide innovative solutions in the pathology sector.

Integration of Advanced Technologies

Starting from October 1, 2025, the integration of Lumea's device will be available as an optional feature on the Maestro Encore. By January 1, 2026, it will become a standard feature, a strategic move designed to streamline laboratory operations. This integration aims to facilitate a seamless transition between specimen grossing and digital pathology workflows, ensuring that healthcare professionals worldwide have access to enhanced diagnostic capabilities.

Francis X. Dirksmeier, CEO of Mopec Group, expressed enthusiasm about the partnership, stating, “This next phase of our collaboration with Lumea reinforces Mopec's commitment to driving innovation that directly benefits patients and laboratory professionals.” Through the adoption of Lumea’s technology, Mopec is taking a giant leap towards delivering comprehensive solutions that enable laboratories to improve diagnostic precision and operational efficiency.

Exclusive Supplier of Lumea Consumables

In another exciting development, Mopec has also become the exclusive supplier of Lumea's consumable products. These essential pre-analytical tissue-handling devices will be made available for purchase through Mopec’s website and distributor channels. The consumables are designed with a focus on preserving tissue quality while improving yield and ensuring the most accurate patient diagnoses.

Key Consumable Products Include:

• - BxBoard®: This advanced tissue collection and transport device is set to replace traditional formaldehyde bottles, simplifying workflows for surgical centers and laboratory personnel while enhancing tissue quality. It’s offered in several configurations to accommodate the unique requirements of different laboratories.

• - BxChip®: An innovative biomimetic organic polymer chip, the BxChip® is capable of securely holding and preserving up to six needle-core biopsies in a consistent orientation. This ensures optimal tissue presentation, minimizing the risk of loss and supporting more confident diagnoses.

Jeff Pemberton, VP of Marketing and Commercial Strategy at Mopec, remarked, “We are thrilled to be the exclusive supplier of these consumables. Together, Mopec and Lumea are equipping labs with the tools they need to ensure consistency, reliability, and patient-focused outcomes.”

Pioneering the Future of Diagnostic Accuracy

This expanded partnership is a testament to Mopec’s mission to empower pathology professionals with advanced products and solutions. By integrating state-of-the-art equipment with consumables optimized for pre-analytical processes, Mopec and Lumea are shaping a brighter future for diagnostic accuracy and efficiency in pathology.

Mopec Group, which originated in 1992 and is headquartered in Madison Heights, Michigan, stands out as a leading supplier and manufacturer in the anatomic and forensic pathology industry. Known for its innovation and engineering excellence, this company is dedicated to providing complete solutions that serve hospitals, universities, morgues, and more.

On the other hand, Lumea has made major strides in digital pathology, specializing in cost-effective, efficient technologies that enhance workflow automation. With a decade of experience, Lumea has set a benchmark in primary clinical digital pathology, leading in quality and efficiency across the U.S. market.

Ultimately, the collaboration between Mopec and Lumea not only enhances lab workflows but significantly contributes to improved patient outcomes, marking a pivotal evolution in the field of pathology. For more information about Mopec and its innovative solutions, visit www.mopecgroup.com and www.lumeadigital.com.